The growth of Viagra and its effect on the medicinal landscape presents a complicated question for shareholders. While the first sales data were impressive, the exclusivity has expired, leading to a wave of copycat https://ihannafqlm115377.diowebhost.com/96581006/sildenafil-and-big-pharma-a-risky-opportunity